WD Rutherford LLC Buys New Shares in Cardinal Health, Inc. $CAH

Posted by Stanley Muller on Jul 2nd, 2026

WD Rutherford LLC bought a new position in Cardinal Health, Inc. (NYSE:CAH – Free Report) in the 1st quarter, according to the company in its most recent disclosure with the SEC. The institutional investor bought 2,675 shares of the company’s stock, valued at approximately $565,000.

A number of other institutional investors have also bought and sold shares of the business. Redhawk Wealth Advisors Inc. lifted its position in shares of Cardinal Health by 0.5% in the fourth quarter. Redhawk Wealth Advisors Inc. now owns 9,255 shares of the company’s stock valued at $1,902,000 after acquiring an additional 48 shares in the last quarter. HF Advisory Group LLC grew its position in shares of Cardinal Health by 0.9% during the fourth quarter. HF Advisory Group LLC now owns 5,227 shares of the company’s stock worth $1,074,000 after purchasing an additional 49 shares in the last quarter. Hillsdale Investment Management Inc. raised its stake in Cardinal Health by 0.9% during the 4th quarter. Hillsdale Investment Management Inc. now owns 5,760 shares of the company’s stock valued at $1,184,000 after purchasing an additional 50 shares during the period. Generali Asset Management SPA SGR raised its stake in Cardinal Health by 11.0% during the 4th quarter. Generali Asset Management SPA SGR now owns 513 shares of the company’s stock valued at $105,000 after purchasing an additional 51 shares during the period. Finally, Stephens Inc. AR lifted its holdings in Cardinal Health by 0.9% in the 4th quarter. Stephens Inc. AR now owns 5,951 shares of the company’s stock worth $1,223,000 after purchasing an additional 52 shares in the last quarter. Hedge funds and other institutional investors own 87.17% of the company’s stock.

Cardinal Health Stock Up 0.3%

Shares of CAH opened at $238.31 on Thursday. The company has a market cap of $55.82 billion, a PE ratio of 36.44, a P/E/G ratio of 1.30 and a beta of 0.48. The business has a fifty day moving average of $207.54 and a 200 day moving average of $211.22. Cardinal Health, Inc. has a 52-week low of $137.75 and a 52-week high of $240.93.

Cardinal Health (NYSE:CAH – Get Free Report) last announced its earnings results on Thursday, April 30th. The company reported $3.17 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.79 by $0.38. Cardinal Health had a negative return on equity of 92.61% and a net margin of 0.62%.The business had revenue of $60.94 billion during the quarter, compared to analyst estimates of $62.10 billion. During the same quarter in the previous year, the business earned $2.35 earnings per share. The company’s revenue for the quarter was up 11.0% compared to the same quarter last year. Cardinal Health has set its FY 2026 guidance at 10.700-10.80 EPS. As a group, research analysts anticipate that Cardinal Health, Inc. will post 10.76 earnings per share for the current fiscal year.

Cardinal Health Increases Dividend

The business also recently declared a quarterly dividend, which will be paid on Wednesday, July 15th. Investors of record on Wednesday, July 1st will be paid a $0.5158 dividend. The ex-dividend date of this dividend is Wednesday, July 1st. This represents a $2.06 annualized dividend and a yield of 0.9%. This is a boost from Cardinal Health’s previous quarterly dividend of $0.51. Cardinal Health’s payout ratio is 31.19%.

Analyst Ratings Changes

Several research firms have weighed in on CAH. Wall Street Zen downgraded Cardinal Health from a “strong-buy” rating to a “buy” rating in a research note on Monday, June 15th. Robert W. Baird set a $248.00 target price on shares of Cardinal Health in a report on Friday, May 1st. Morgan Stanley upped their target price on shares of Cardinal Health from $245.00 to $255.00 and gave the stock an “overweight” rating in a research report on Tuesday, April 28th. Wells Fargo & Company cut their target price on shares of Cardinal Health from $256.00 to $245.00 and set an “overweight” rating for the company in a research note on Friday, May 1st. Finally, TD Cowen boosted their price target on shares of Cardinal Health from $251.00 to $255.00 and gave the stock a “buy” rating in a research note on Friday, May 1st. Fourteen investment analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company. According to MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average price target of $246.93.

Read Our Latest Stock Report on Cardinal Health

Cardinal Health Profile

(Free Report)

Cardinal Health is a multinational healthcare services and products company headquartered in Dublin, Ohio. Tracing its roots to the early 1970s, the company has grown into a major provider of supply chain and distribution services for the healthcare sector. Cardinal Health operates across a range of service lines that support hospitals, health systems, pharmacies, physician offices and clinical laboratories.

The company’s core activities include the wholesale distribution of branded and generic pharmaceuticals, the supply and distribution of medical-surgical products, and the provision of logistics and inventory management solutions.

Institutional Ownership by Quarter for Cardinal Health (NYSE:CAH)

Receive News & Ratings for Cardinal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardinal Health and related companies with MarketBeat.com's FREE daily email newsletter.